State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT06919224 N/A
Recruiting
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults Wi...
Condition
Sickle Cell Disease
Enrollment
287 pts
Location
United States
Sponsor
Ohio State University
NCT05932862 Phase 1
Recruiting
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With...
Condition
Advanced Solid Tumor
Enrollment
429 pts
Location
United States
Sponsor
Exelixis
NCT06813820 N/A
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Condition
Left Ventricle Remodeling
Enrollment
135 pts
Location
United States
Sponsor
BioVentrix
NCT06742723 Phase 3
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05636618 Phase 1, Phase 2
Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2...
Condition
Neuroendocrine Tumors Unresectable
Enrollment
260 pts
Location
United States
Sponsor
Perspective Therapeutics
NCT05630794 Phase 1
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Condition
Colorectal Adenomatous Polyp
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05100862 Phase 3
Recruiting
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Par...
Condition
Relapsed/Refractory Follicular Lymphoma
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
BeiGene
NCT06850038 N/A
Recruiting
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay)...
Condition
Alagille Syndrome
Enrollment
30 pts
Location
United States
Sponsor
Ipsen
NCT05504291 Phase 2
Recruiting
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Condition
Bilateral Retinoblastoma
Enrollment
26 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06369298 Phase 2
Recruiting
Study of JK07 in Patients With Chronic Heart Failure
Condition
Heart Failure With Reduced Ejection Fraction
Enrollment
282 pts
Location
United States, Canada, China
Sponsor
Salubris Biotherapeutics Inc
NCT03638999 EARLY_Phase 1
Recruiting
NSAIDs Stent Study
Condition
Ureteral Stent Placement
Enrollment
36 pts
Location
United States
Sponsor
Washington University School o
NCT06741228 Phase 3
Recruiting
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Condition
Generalized Anxiety Disorder
Enrollment
200 pts
Location
United States
Sponsor
Definium Therapeutics US, Inc.
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
NCT07097506 Phase 2
Recruiting
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
Condition
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
40 pts
Location
United States
Sponsor
Washington University School o
NCT06118281 Phase 3
Recruiting
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo...
Condition
Cardiovascular Risk
Enrollment
10,000 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT07076407 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X...
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
NCT06805240 N/A
Recruiting
EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr ...
Condition
Healthy
Enrollment
81 pts
Location
United States
Sponsor
Laborie Medical Technologies I
NCT05846438 N/A
Recruiting
Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Brea...
Condition
Infections
Enrollment
100 pts
Location
United States
Sponsor
University of Missouri-Columbi
NCT06238648 Phase 2
Recruiting
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in...
Condition
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Enrollment
120 pts
Location
United States
Sponsor
Academic and Community Cancer
NCT05673148 Phase 3
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatme...
Condition
Metastatic Colorectal Adenocarcinoma
Enrollment
364 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07211178 N/A
Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor...
Condition
Breast Cancer
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
NCT03992625 N/A
Recruiting
Clinical Outcomes for Deep Brain Stimulation
Condition
Parkinson Disease
Enrollment
1,000 pts
Location
United States
Sponsor
Washington University School o